March 19, 2019 | Biosimilar Development

Biosimilars And The BPCIA: Past, Present, And Future

1 min

Ha Kung Wong co-authored "Biosimilars And The BPCIA: Past, Present, And Future" in Biosimilar Development on March 19, 2019. Here is an excerpt.

While the biosimilar market in the U.S. has gotten off to a relatively slow start compared to Europe, where biosimilars have been available since 2006, it has recently gained momentum and will continue to grow in the coming years as more “blockbuster” biologics lose regulatory exclusivity and patent protection. Here we review our observations in the biosimilar space since the enactment of the 2009 Biologics Price Competition and Innovation Act (BPCIA) and our view of the future of biosimilars and related patent disputes.